SCHEMBL8128271

SCHEMBL8128271

CC(=O)OC(=O)CC[C@@H](N)C(=O)OC(C)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 2/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
GRM8 O00222 1/20 0.34
GRM6 O15303 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GSR P00390 1/20 0.34
CYP1A2 P05177 1/20 0.34
GRIK1 P39086 1/20 0.34
GRM5 P41594 1/20 0.34
GRIA1 P42261 1/20 0.34
GRIA2 P42262 1/20 0.34
GRIA3 P42263 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
GRIA4 P48058 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIK2 Q13002 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1606668 1.00 SLC1A1 (0.36) SLC1A1ALDH1A1TSHRGRM8GRM6
SCHEMBL8838340 1.00 SLC1A1 (0.36) SLC1A1ALDH1A1TSHRGRM8GRM6
Hydrochloric Acid SCHEMBL27564185 0.98 SLC1A1 (0.35) SLC1A1ALDH1A1TSHRGRM8GRM6
SCHEMBL26108975 0.98 SLC1A1 (0.35) SLC1A1ALDH1A1TSHRGRM8GRM6
SCHEMBL30611208 0.87 CYP1A2 (0.44) SLC1A1ALDH1A1TSHRCYP1A2ALOX15
SCHEMBL23200441 0.84 CYP1A2 (0.54) SLC1A1TSHRGRM8GRM6GRIN2D
SCHEMBL8838342 0.84 CYP1A2 (0.54) SLC1A1TSHRGRM8GRM6GRIN2D
SCHEMBL28818337 0.84 KMT2A (0.52) SLC1A1ALDH1A1TSHRGRM8GRM6
SCHEMBL2803038 0.84 SLC1A1 (0.54) SLC1A1ALDH1A1TSHRGRM8GRM6
SCHEMBL972770 0.84 KMT2A (0.52) SLC1A1ALDH1A1TSHRGRM8GRM6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801626-A1 USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES Biohaven Pharmaceutical Holding Company Ltd. (US) 2021-04-14 EP disclosed
CN-1968686-A Guanylhydrazone salts, compositions, processes of making and methods of using CYTOKINE PHARMASCIENCES INC (US) 2007-05-23 CN disclosed
JP-2000173876-A SEALER FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR PROVIDED THEREWITH RUBYCON CORP 2000-06-23 JP disclosed